GenomicsbioRxivPreprint
Tissue specificity and chromosomal alterations shape divergent immune programs in HRD tumors
D. Gulhan, David Barras, Marco Mina…·Denarda Dangaj Laniti
This study identifies two immune archetypes in HRD tumors—immune-inflamed and immune-evasive—linked to chromosomal instability and lineage, informing biomarker-driven therapies.
DOI 10.1101/2025.10.13.681986